1-(2-Fluoro-4-nitro-phenyl)-4-methyl-piperidine, 5g

Trimethyl((4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethynyl)silane, 98%, 1g

Azelaic acid, min. 80%, 25 g, plastic packaging.

7-BROMO-6-METHYL-2,3-DIHYDRO-1H-INDEN-1-ONE, 95%, 1g

2,4-Difluoro-6-nitrophenol, 95.0%, 5g

4-(Methylsulfonyl)benzylamine, 95.0%, 10g

Methyl 3-Bromopropionate>99.0%(GC)25g

3-METHYLQUINOLINE-2-CARBOXYLIC ACID, 95%, 250mg

7-Amino-5-(4-methoxybenzyl)-5H-dibenzo[b,d]azepin-6(7H)-one hydrochloride, 97%, 500mg

6-(4-chlorophenyl)pyridazine-3-thiol, 95.0%, 250mg

1-(1-Benzyl-2,6-dimethyl-4-piperidyl)cyclopropanamine, 98%, 1g

2-[1,2,4]Triazol-1-yl-propionic acid, 95.0%, 250mg

(R,R)-(-)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediamine>98.0%(HPLC)(N)25g